BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18929129)

  • 1. Changes of central visual receptive fields in experimental glaucoma.
    Sharma SC
    Prog Brain Res; 2008; 173():479-91. PubMed ID: 18929129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of visual receptive fields in experimental glaucoma.
    King WM; Sarup V; Sauvé Y; Moreland CM; Carpenter DO; Sharma SC
    Vis Neurosci; 2006; 23(1):137-42. PubMed ID: 16597357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in visual fields and lateral geniculate nucleus in monkey laser-induced high intraocular pressure model.
    Sasaoka M; Nakamura K; Shimazawa M; Ito Y; Araie M; Hara H
    Exp Eye Res; 2008 May; 86(5):770-82. PubMed ID: 18378230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal innervation and optic neuropathy in macacque monkeys with laser- or anterior chamber perfusion-induced short-term elevation of intraocular pressure.
    Albrecht May C; Kaufman PL; Lütjen-Drecoll E; Scholz M
    Exp Eye Res; 2006 Jun; 82(6):1060-7. PubMed ID: 16466715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.
    Urcola JH; Hernández M; Vecino E
    Exp Eye Res; 2006 Aug; 83(2):429-37. PubMed ID: 16682027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What changes can we expect in the brain of glaucoma patients?
    Gupta N; Yücel YH
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S122-6. PubMed ID: 17998036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual function measures in experimental glaucoma.
    Johnson CA
    J Glaucoma; 1997 Dec; 6(6):351-2. PubMed ID: 9407360
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the ETB receptor in retinal ganglion cell death in glaucoma.
    Krishnamoorthy RR; Rao VR; Dauphin R; Prasanna G; Johnson C; Yorio T
    Can J Physiol Pharmacol; 2008 Jun; 86(6):380-93. PubMed ID: 18516102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with polarimetry and spectral domain OCT.
    Horn FK; Mardin CY; Laemmer R; Baleanu D; Juenemann AM; Kruse FE; Tornow RP
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):1971-7. PubMed ID: 19151389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model.
    Holcombe DJ; Lengefeld N; Gole GA; Barnett NL
    Br J Ophthalmol; 2008 May; 92(5):683-8. PubMed ID: 18296504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptive field properties of cat retinal ganglion cells during short-term IOP elevation.
    Zhou Y; Wang W; Ren B; Shou T
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2758-64. PubMed ID: 8188469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of melanopsin-containing retinal ganglion cells in a rat glaucoma model.
    Wang HZ; Lu QJ; Wang NL; Liu H; Zhang L; Zhan GL
    Chin Med J (Engl); 2008 Jun; 121(11):1015-9. PubMed ID: 18706250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Long-term measurement variability with scanning laser polarimetry employing enhanced corneal compensation: an early sign of glaucoma progression.
    Tóth M; Holló G
    J Glaucoma; 2008; 17(7):571-7. PubMed ID: 18854736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glaucomatous optic neuropathy].
    Nesterov AP
    Vestn Oftalmol; 1999; 115(4):3-6. PubMed ID: 10523955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glaucoma--neurodegenerative disease].
    Tataru LC; Bogdănici CM
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1120-5. PubMed ID: 20191885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.